*HistAI CELLDX is not for primary diagnosis. For Research Use only!

We are thrilled to announce the launch of our groundbreaking cross-platform viewer tool empowered with AI. HistAI CELLDX™ is now available for pathologists and researchers worldwide. This marks a significant milestone in our journey to transform the field of digital pathology through advanced AI technology.

Why CELLDX?

CELLDX is more than just a convenient slide viewer; although designed to ease the transition from microscopes to computers, it represents a new approach to pathology. Through the integration of AI and machine learning, CELLDX enhances the capabilities of pathologists, enabling them to automate many routine tasks with unprecedented accuracy and efficiency.

Cross-Platform Accessibility

Whether on your mobile, tablet, or desktop, CELLDX offers a seamless experience when working with whole slide images. Analyse, highlight, zoom, rotate, and measure distances with just a few touches!

Collaborative Tools

Facilitate real-time collaboration and knowledge-sharing with peers, breaking through geographical barriers. Simply share a link to initiate limitless collaboration and exchange insights seamlessly.

Simple User-Friendly Interface

Tailored for pathologists of all tech proficiency levels, ensuring a user-friendly experience and a seamless learning curve—no manuals required.

Cherry on Top - AI-Widgets

Harnessing state-of-the-art AI algorithms, our accompanied automated analysis begins with the CELLDX Melanocytic Lesions Suite. Capable of distinguishing melanoma from nevus, displaying tumor area, detecting ulcerations, and measuring tumor depth and diameter, it has been meticulously trained and validated on the largest private dataset of cutaneous melanoma and nevi. It's accuracy was verified on both private and public data.

Our commitment extends to regularly introducing new AI widgets. Stay tuned for our next major update, featuring the Non-Melanocytic Lesions Suite and lymph-node metastases detection.

Try CELLDX for Free Now!

"To celebrate the launch of CELLDX, we are thrilled to offer everyone the opportunity to experience it firsthand, completely free of charge, including 20 runs of AI widgets. We are delighted to provide the community with a chance to explore the potential of computational pathology and witness how it can revolutionize their practice." Alex Pchelnikov, Founder and CEO at HistAI

Join Us in Shaping the Future

At HistAI, we believe in continuous innovation and collaboration. As you explore our platform, we invite you to share your feedback share your feedback and suggestions. Your insights are invaluable in shaping the future of digital pathology.